Refocus Group is a pioneering medical device company founded in 1994, dedicated to developing innovative solutions for vision disorders, with a specific focus on presbyopia treatment. The company operates within the industries of Biotechnology, Health Care, and Medical Devices.
Having recently secured a $7.00M funding round investment on 02 March 2005, Refocus Group is propelled towards advancing its research and development efforts in the field of vision disorder treatments. This funding injection is indicative of the confidence and potential that investors see in the company's mission and strides in medical innovation.
With an unwavering commitment to revolutionizing treatments for presbyopia and other vision disorders, Refocus Group continues to be a compelling player in the medical device industry, poised for further growth and impact in the realm of ophthalmic healthcare.
